Subsequent Events (Details) $ in Thousands |
3 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|
|
Oct. 21, 2024
USD ($)
item
|
Sep. 30, 2024
USD ($)
|
Sep. 30, 2023
USD ($)
|
Sep. 30, 2024
USD ($)
|
Sep. 30, 2023
USD ($)
|
|
| Subsequent Event | |||||
| Payments of consideration under RPAs, AAAs and CPPAs | $ 37,000 | $ 14,650 | |||
| Revenue from contracts with customers | $ 25 | $ 225 | $ 6,050 | $ 1,350 | |
| Subsequent Event | Twist Bioscience | Royalty Purchase Agreement | |||||
| Subsequent Event | |||||
| Percentage of economics of programs acquired | 50.00% | ||||
| Number of partners associated with programs | item | 30 | ||||
| Upfront payment | $ 15,000 | ||||
| Maximum milestone payments entitled to receive | $ 500,000 | ||||
| Percentage of royalties entity is entitled to receive | 50.00% | ||||
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Maximum eligible milestone payments receivable upon achievement of milestones. May include, but not limited to, development, regulatory, commercial, sales-based and clinical milestones. No definition available.
|
| X | ||||||||||
- Definition Percentage of royalties entity is entitled to receive on future commercial sales. No definition available.
|
| X | ||||||||||
- Definition Represents the number of partners associated with programs. No definition available.
|
| X | ||||||||||
- Definition Amount of cash outflow for consideration under agreements, including Royalty Purchase Agreements (RPAs), Assignment and Assumption Agreements (AAAs), Commercial payment purchase agreement (CPPAs) and other agreements classified as investing activities. Payments may include upfront payments, one-time payments, milestone payments and contingent consideration payments. No definition available.
|
| X | ||||||||||
- Definition Purchased percentage of economics of early-stage programs. No definition available.
|
| X | ||||||||||
- Definition The cash outflow for initial payment under agreement. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|